CNBC just did a documentary on research report sites, they mentioned flash market research (google em) and how retail investors have made millions on their picks because they come out ahead of the street. Flash market research is now profiling AEMD, this could be HUGE for us!!!
At present, small molecule therapies are the most widely used approach in cancer treatments. In many cases they are rendered ineffective due to resistance or to debilitating side effects, leaving the oncology landscape extremely challenged to develop new, innovative approaches. Immunotherapy, which uses the body's immune system to fight tumors, has delivered some very promising advanced data in the last decade, with Dendreon Corporation (DNDN) becoming the first immunotherapy to garner FDA approval in April 2010 as a new treatment for certain men with advanced prostate cancer